Trial Profile
Study of ONO-1101 in Patients Scheduled for Coronary Angiography, a Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors Ono Pharmaceutical
- 04 Apr 2014 New trial record
- 11 Dec 2008